ParkLGHowie-EsquivelJWhooleyMAet al. Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. Eur J Cardiovasc Nurs2015; 14: 264–273.
3.
WuJRMoserDK.Medication adherence mediates the relationship between heart failure symptoms and cardiac event-free survival in patients with heart failure. J Cardiovasc Nurs2018; 33: 40–46.
4.
SenftYKirschMDenhaerynckKet al. Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. Eur J Cardiovasc Nurs2018; 17: 356–367.
5.
TurnerLShamseerLAltmanDGet al. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Cochrane Database Syst Rev2012; 1: 60.
6.
HelmyRZulligLLDunbar-JacobJet al. ESPACOMP Medication Adherence Reporting Guidelines (EMERGE): a reactive-Delphi study protocol. BMJ Open2017; 7: e013496.
7.
De GeestSZulligLLDunbar-JacobJet al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med2018; 169: 30–35.
8.
VrijensBDe GeestSHughesDAet al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol2012; 73: 691–705.